IDXX - IDEXX Laboratories, Inc.
| Previous Close | 251.86 |
| Open | 253.91 |
| Bid | 240.00 x 800 |
| Ask | 272.77 x 900 |
| Day's Range | 251.15 - 254.50 |
| 52 Week Range | 176.11 - 294.57 |
| Volume | 275,947 |
| Avg. Volume | 451,011 |
| Market Cap | 21.563B |
| Beta (3Y Monthly) | 0.72 |
| PE Ratio (TTM) | 52.16 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- MarketWatch
Had enough of ‘OK, boomer’? Not if you want to make money with these stocks
Internet memes can be funny — and annoying — but they can also remind us of lucrative investment opportunities from time to time. A current trend is for young adults to make fun of baby boomers for being clueless. Baby boomers were born during the postwar economic expansion from 1946 through 1964.
- Insider Monkey
Should You Avoid IDEXX Laboratories, Inc. (IDXX)?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Our research shows that most of the stocks that smart money likes historically generate strong […]
- Thomson Reuters StreetEvents
Edited Transcript of IDXX earnings conference call or presentation 31-Oct-19 12:30pm GMT
Q3 2019 IDEXX Laboratories Inc Earnings Call
- Zacks
Top-Ranked Nasdaq-100 ETF at New High: 5 Best Stocks
Likelihood of a soon-to-be-signed U.S.-China trade deal, upbeat holiday season sales expectations and decent earnings have led the Nasdaq-100 ETF to a new high.
- TheStreet.com
Are These 2 Stocks Going to the Dogs?
The charts of IDEXX Laboratories and Zoetis have weakened recently, and while the Westminster Dog Show is not for a few more months, it looks like these stocks could be going to the dogs. In this daily bar chart of IDXX, below, we can see that prices traded sideways since June with buyers showing up around $260 until today.
- Zacks
Impressive Near-Term Outlook for Medical Instruments Industry
Impressive Near-Term Outlook for Medical Instruments Industry
- Zacks
IDEXX (IDXX) Tops Q3 Earnings Estimates, Lowers EPS View
IDEXX (IDXX) impresses investors with solid third-quarter 2019 results on robust performance across all business segments.
- Benzinga
13 Stocks With The Highest Returns On Equity
Return on equity is one of the most popular ways for investors to assess the efficiency of a business before they buy a stock. Return on equity is a measure of profitability relative to shareholder’s equity. ...
- Zacks
Idexx Laboratories (IDXX) Surpasses Q3 Earnings and Revenue Estimates
Idexx (IDXX) delivered earnings and revenue surprises of 9.73% and 1.33%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Investing.com
IDEXX Labs Earnings, Revenue Beat in Q3
Investing.com - IDEXX Labs reported third quarter earnings that beat analysts' expectations on Thursday and revenue that topped forecasts.
- Zacks
Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More
Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.
- Benzinga
12 Stocks With The Highest Returns On Assets
There are many ways for fundamental investors to gauge the profitability of a business, and one common method is looking at return on assets. Return on assets is simply a measure of profitability relative ...
- Simply Wall St.
Are IDEXX Laboratories, Inc.’s (NASDAQ:IDXX) High Returns Really That Great?
Today we'll look at IDEXX Laboratories, Inc. (NASDAQ:IDXX) and reflect on its potential as an investment...
- Investor's Business Daily
How Your Fur Baby Is Bolstering A $45 Billion Health Business
Fido and Fluffy have health concerns, too, and animal health companies like Zoetis and Idexx Laboratories are in hot pursuit of the rapidly developing pet health market.
- Zacks
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
What's in Store for IDEXX Laboratories' (IDXX) Q3 Earnings?
Growth in Rapid Assays and Veterinary Software revenues is expected to get reflected in IDEXX's (IDXX) third-quarter results.
- Zacks
Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now
Investors continue to be optimistic about IDEXX's (IDXX) performance.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On IDEXX Laboratories, Inc. (IDXX)
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after […]
- Investopedia
7 EBITDA Growth Stocks That Can Outperform in a Volatile Market
This is the second of two stories that Investopedia is devoting to a report from Goldman Sachs recommending stocks with longterm stable profit growth.
- Zacks
IDEXX's Kidney Function Test Included in IRIS Staging Views
IDEXX (IDXX) is upbeat about the inclusion and approval of the SDMA-based renal care staging guidelines.
- Simply Wall St.
IDEXX Laboratories (NASDAQ:IDXX) Shareholders Have Enjoyed A Whopping 347% Share Price Gain
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
- Investor's Business Daily
Two Leading Medical Stocks To Know As They Approach Buy Points
Shares of medical stocks Idexx Laboratories and Masimo approached breakouts Friday as Wall Street enjoyed a third day of gains. Both stocks are now in the process of forming flat bases.
- GuruFocus.com
Terry Smith: The British Fund Manager Beating Buffett
It could be worth following the investment ideas of this successful manager. Continue reading...
- Simply Wall St.
If You Like EPS Growth Then Check Out IDEXX Laboratories (NASDAQ:IDXX) Before It's Too Late
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Zacks
Idexx (IDXX) Up 8% Since Last Earnings Report: Can It Continue?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
